Sinphar Pharmaceutical Co.,Ltd.

1734

TW0001734002

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
36.5 ^TWD	+0.83%		+0.41%	+7.51%

May. 15	Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 26	Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Sinphar Pharmaceutical Co., Ltd.(TSEC:1734) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index

December 01, 2015 at 12:00 am EST

Latest news about Sinphar Pharmaceutical Co.,Ltd.

Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 12	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-11	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-12	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-29	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-11	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-13	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-25	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-12	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-12	CI
Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-12	CI
Sinphar Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-28	CI
Sinphar Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2018	18-11-12	CI
Sinphar Pharmaceutical Co., Ltd.(TSEC:1734) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	15-12-01	CI
QingHai Gelatin Company Limited cancelled the acquisition of remaining 25% stake in Qinghai Mingxing Bioengineering Co., Ltd. from Sinphar Pharmaceutical Co., Ltd..	14-03-28	CI

Chart Sinphar Pharmaceutical Co.,Ltd.

Duration

Period

More charts

Sinphar Pharmaceutical Co., Ltd. is principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company is also engaged in the sales of functional food products. The Companyâs principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The Company mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.

Sector

Pharmaceuticals

Calendar

2024-06-18 - Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SINPHAR PHARMACEUTICAL CO.,LTD.	+7.51%	188M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B